Symbol | Kapitalizacja rynkowa | Cena | Zmiana % | Wolumen | Realny Wolumen | Cena/Zysk | Zysk na akcję rzeczywisty TTM | Wzrost rzeczywistego zysku na akcję Ostatnie 12 miesięcy r/r | Rentowność dywidend % TTM | Ocena Analityków |
---|---|---|---|---|---|---|---|---|---|---|
GRFGRIFOLS S.A. | 5.051 B EUR | 8.086 EUR | −3.46% | 3.153 M | 1.15 | 34.96 | 0.23 EUR | −71.83% | 0.00% | Kup |
ROVILABORATORIOS FARMACEUTICOS ROVI S.A. | 4.247 B EUR | 84.70 EUR | +6.41% | 159.176 K | 2.76 | 26.30 | 3.22 EUR | −14.01% | 1.32% | Kup |
ALMALMIRALL S.A. | 1.755 B EUR | 8.465 EUR | +0.95% | 176.361 K | 1.36 | — | −0.18 EUR | +23.28% | 1.78% | Kup |
FAEFAES FARMA, S.A. | 1.021 B EUR | 3.320 EUR | +1.37% | 297.907 K | 1.40 | 11.22 | 0.30 EUR | +4.19% | 4.57% | Neutralnie |
PHMPHARMA MAR, S.A. | 520.278 M EUR | 28.82 EUR | +1.41% | 58.934 K | 1.37 | 520.22 | 0.06 EUR | — | 1.85% | Kup |
RJFLABORATORIO REIG JOFRE, S.A. | 199.301 M EUR | 2.52 EUR | 0.00% | 4.94 K | 0.53 | — | — | — | 1.29% | — |
PRMPRIM, S.A. | 172.88 M EUR | 10.00 EUR | −1.96% | 5.712 K | 2.06 | — | — | — | 2.91% | — |
ORYORYZON GENOMICS, S.A. | 125.461 M EUR | 1.980 EUR | −1.88% | 36.301 K | 0.18 | — | −0.06 EUR | +24.94% | 0.00% | Silne kup |
NTHNATURHOUSE HEALTH, S.A | 100.116 M EUR | 1.670 EUR | 0.00% | 10.557 K | 0.41 | 8.86 | 0.19 EUR | +25.35% | 7.28% | — |
PANGPANGAEA ONCOLOGY S.A. | 52.057 M EUR | 1.71 EUR | 0.00% | 2.8 K | 0.02 | — | — | — | 0.00% | — |
BSTBIOTECHNOLOGY ASSETS, S.A. | 20.602 M EUR | 0.3550 EUR | −0.70% | 62.651 K | 0.49 | — | — | — | 0.00% | — |
VYTVYTRUS BIOTECH, S.A. | 17.219 M EUR | 2.30 EUR | −4.96% | 5.237 K | 3.05 | — | — | — | 0.00% | Silne kup |
LABLABIANA HEALTH, S.A. | 11.915 M EUR | 1.65 EUR | 0.00% | 0 | 0.00 | — | — | — | 0.00% | — |